Treatment Procedures
Chemotherapy: Chemotherapy drugs, such as cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP regimen), are commonly used to kill cancerous lymphocytes and reduce tumor burden. Combination chemotherapy regimens may also include newer agents like rituximab, bendamustine, or lenalidomide, depending on the subtype of NHL.
Immunotherapy: Monoclonal antibodies, such as rituximab, obinutuzumab, and pembrolizumab, target specific proteins on cancer cells, marking them for destruction by the immune system. Immunotherapy may be used alone or in combination with chemotherapy to enhance treatment effectiveness.
Targeted Therapy: Targeted therapies, such as tyrosine kinase inhibitors (e.g., imatinib, ibrutinib), proteasome inhibitors (e.g., bortezomib), and BCL-2 inhibitors (e.g., venetoclax), disrupt specific pathways involved in cancer cell growth and survival, leading to more precise and effective treatment with fewer side effects.
Radiation Therapy: Radiation therapy delivers high-energy beams to cancerous lymph nodes or other affected areas, destroying cancer cells and shrinking tumors. It may be used as a standalone treatment or in combination with other modalities, depending on the extent and location of the disease.
Stem Cell Transplantation: For eligible patients with aggressive NHL or relapsed/refractory disease, high-dose chemotherapy followed by autologous or allogeneic stem cell transplantation may be recommended to eradicate cancer cells and restore healthy bone marrow function.